Denis Taschuk


President, CEO and Director,  

Radient Technologies 

Mr. Taschuk has thirty years of business experience, including corporate strategy development, manufacturing, market development and finance.  He is currently President and CEO of Radient Technologies Inc.  (TSXV: RTI)  In June 2014 he oversaw the reverse takeover of Madison Capital Corporation by RTI, leading to RTI being a TSXV listed company.  Prior to joining Radient 2011, Mr. Taschuk was a partner and the CEO of Jag Flocomponents LP which manufactured industrial valves and had operations in six countries and customers in over twenty countries.  In 2001 he successfully led the initial public offering on the TSX, for Cytovax Biotechnologies Inc. and was previously a Director of the International Diabetes Federation and a director and Chair of the Board of the Canadian Diabetes Association.  Mr. Taschuk is a Chartered Accountant and holds a Bachelor of Commerce degree from the University of Alberta.